Axcynsis Therapeutics
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A neuroscience biotech developing small molecule drugs for CNS disorders.
Neuroscience
Technology Platform
Platform for discovering novel small molecules that target specific pathways in the central nervous system.
Opportunities
Addressing massive unmet medical needs in neurodegenerative and psychiatric diseases with novel mechanisms.
Risk Factors
Extremely high risk of clinical failure inherent in neuroscience drug development due to complex biology and poor translatability.
Competitive Landscape
Faces intense competition and high scientific hurdles in the CNS drug development landscape.